Background: Patients with cystic fibrosis (CF) may be at risk for micronutrient depletion, particularly during periods of illness and infection. The purpose of this study was to investigate serum micronutrient status over time in adults with CF initially hospitalized with a pulmonary exacerbation. Materials and Methods: This was an ancillary study of a multicenter trial investigating the role of high-dose vitamin D supplementation in 24 adults with CF (mean age, 29.6 ± 7.3 years). We measured serum concentrations of copper (Cu), iron (Fe), calcium (Ca), magnesium (Mg), potassium (K), and sulfur (S) in subjects at the beginning of a pulmonary exacerbation and again at 3 months. Results: Serum concentrations of Cu, Fe, and Ca were significantly lower at baseline compared with 3 months following the pulmonary exacerbation (Cu: baseline, 1.5 ± 0.6 vs 3 months, 1.6 ± 0.6 µg/mL, P = .027; Fe: 0.8 ± 0.3 vs 1.3 ± 1.1 µg/mL, P = .026; Ca: 9.7 ± 0.8 vs 10.8 ± 2.0 mg/dL, P = .024). Serum concentrations of K, Mg, and S did not change over time (K: baseline, 4.9 ± 0.3 vs 3 months, 5.1 ± 0.5 mEq/L; Mg: 1.8 ± 0.2 vs 2.0 ± 0.3 mg/dL; S: 1288.6 ± 343 vs 1309.9 ± 290 µg/mL; P > .05 for all). Conclusion: Serum concentrations of Cu, Fe, and Ca increased significantly several months following recovery from acute pulmonary exacerbation in adults with CF. This may reflect decreased inflammation, improved food intake, and/or increased absorption following recovery.
FarrellPMRosensteinBJWhiteTB. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14.
2.
Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2011 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2012
3.
MatelJLMillaCE. Nutrition in cystic fibrosis. Sem Resp Crit Care Med. 2009;30(5):579–586.
4.
KeremEReismanJCoreyMCannyGJLevisonH. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326:1187-1191.
5.
CourtneyJMBradleyJMccaughanJ. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007;42(6):525-532.
6.
KraemerRRüdebergAHadornBRossiE. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978;67:33-37.
7.
OliverAAlarconTCaballeroECantónR. Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis. Enferm Infect Microbiol Clin. 2009;27(2):89-104.
8.
DodgeJATurckD. Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol. 2006;20(3):531-546.
9.
TangprichaVKellyAStephensonA. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012;97(4):1082-1093.
10.
SiwamogsathamODongWBinongoJN. Relationship between fat-soluble vitamin supplementation and blood concentrations in adolescent and adult patients with cystic fibrosis. Nutr Clin Pract. 2014;29(4):491-497.
11.
SiwamogsathamOAlvarezJATangprichaV. Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):422-429.
12.
DamphousseVMailhotMBerthiaumeYRabasa-LhoretRMailhotG. Plasma zinc in adults with cystic fibrosis: correlations with clinical outcomes. J Trace Elem Med Biol. 2014;28(1):60-64.
13.
CantinAMWhiteTBCrossCE. Antioxidants in cystic fibrosis: conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003. Free Radic Biol Med. 2007;42:15-31.
14.
MichaikeB. Selenium speciation in human serum of CF patients compared to serum from healthy persons. J Chromatogr A. 2004;1058:203-208.
15.
MichelSHMaqboolAHannaMDMascarenhasM. Nutrition management of pediatric patients who have cystic fibrosis. Pediatr Clin North Am. 2009;56(5):1123-1141.
16.
PortalBRichardMJCoudrayC. Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in CF patients. Clin Chim Acta. 1995;234:137-146.
17.
AngstwurmMWGaertnerR. Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9(3):233-238.
18.
WoodLGFitzgeraldDALeeAK. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr. 2003;77:150-159.
19.
KelleherJGoodeHFFieldHPWalkerBEMillerMGLittlewoodJM. Essential element nutritional status in cystic fibrosis. Hum Nutr Appl Nutr. 1986;40(2):79-84.
20.
Van BiervlietSVande VeldeSVan BierflietJPRobberechtE. The effect of zinc supplements in cystic fibrosis patients. Ann Nutr Metab. 2008;52(2):152-156.
21.
DworkinBNewmanLJBerezinSRosenthalWSSchwarzSMWeissL. Low blood selenium levels in patients with cystic fibrosis compared to controls and healthy adults. JPEN J Pareneter Enteral Nutr. 1987;11(1):38-41.
22.
GrossmannREZughaierSMKumariM. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: a randomized, controlled trial. Dermatoendocrinol. 2012;4(2):191.
23.
CoreyMMcLaughlinFJWilliamsMLevisonH. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41:583-591.
24.
LaiHCCoreyMFitzSimmonsSKosorokMRFarrellPM. Comparison of growth status of patients with cysticfibrosis between the United States and Canada. Am J Clin Nutr. 1999;69:531-538.
25.
KillileaANDowningKHKillileaDW. Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells. Cancer Lett. 2007;258:70-79.
26.
StallingsVAStarkLJRobinsonKAFeranchakAPQuintonH. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832-839.
27.
Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2001, http://wwwn.cdc.gov/nchs/nhanes/2001-2002/L40_B.htm#LBXSKSI.
28.
Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2001. http://wwwn.cdc.gov/nchs/nhanes/2011-2012/CUSEZN_G.htm#LBXSCU.
29.
U.S. Department of Health and Human Services. National Center for Health Statistics. First National Health and Nutrition Examination Survey (NHANES I), 1971-1975. Hyattsville, MD: Centers for Disease Control and Prevention.
30.
World Health Organization. Trace Elements in Human Nutrition and Health. Geneva, Switzerland: World Health Organization; 1996.
31.
Society for Endocrinology. Acute Hypercalceaemia. Bristol, UK: Society for Endocrinology; 2013.
32.
Uriu-AdamsJYKeenCL. Copper, oxidative stress, and human health. Mol Aspects Med. 2005;26(4):268-298.
33.
DesaiVKalerSG. Role of copper in human neurological disorders. Am J Clin Nutr. 2008;88(3):855S-858S.
34.
GriffithDPLiffDAZieglerTREsperGJWintonEF. Acquired copper deficiency: a potentially serious and preventable complication following gastric bypass surgery. Obesity. 2009;17(4):827-831.
35.
BestKMcCoyKGemmaSDiSilvestroRA. Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc. Metabolism. 2004;53(1):37-41.
36.
PercivalSSBowserEWagnerM. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr. 1995;62(3):633-638.
37.
YadavKSinghMAnguranaSK. Evaluation of micronutrient profile of North Indian children with cystic fibrosis: a case-control study. Pediatr Res. 2014;75(6):762-766.
38.
PercivalSS. Copper and immunity. Am J Clin Nutr. 1998;67(5):1064S-1068S.
39.
LazarchickJ. Update on anemia and neutropenia in copper deficiency. Curr Opin Hematol. 2012;19(1):58-60.
40.
HowellJMCGawthorneMC. Copper in Animals and Man. Boca Raton, FL: CRC Press; 1987.
41.
PercivalSSKauwellGPBowserEWagnerM. Altered copper status in adult men with cystic fibrosis. J Am Coll Cardiol. 1999;18(6):614-619.
42.
KollertFMullerCTippeltA. Anaemia in chronic respiratory failure. Int J Clin Pract. 2011;65(4):479-486.
43.
Von DrygalskiABillerJ. Anemia in CF: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract. 2008;23:557-563.
44.
WishJB. Assessing iron status: beyond serum ferritin and transferrin saturation. J Am Soc Nephrol. 2006;1(suppl 1):S4-S8.
45.
ZughaierSMAlvarezJASloanJHKonradRJTangprichaV. The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol. 2014;1(1):e19-e25.
46.
OlsonDLSchwenkWF. Nutrition for patients with cystic fibrosis. Nutr Clin Pract. 2004;19(6):575-580.
47.
GiffordAHAlexandruDMLiZ. Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. J Cyst Fibros. 2014;13(3):311-318.
48.
WeissGGoodnoughLT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.
49.
BhudhikanokGSWangM-CMarcusR. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr. 1998;133:18-27.
50.
LaursenEMMølgaardCMichaelsenKFKochCMüllerJ. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child. 1999;81(3):235-240.
51.
SinaasappelMSternMLittlewoodJ. Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2002;1(2):51-75.
52.
HopkinsMHOwenJAhearnT. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res. 2011;4(10):1645-1654.
